Literature DB >> 12432097

Infection of a human hepatoma cell line by hepatitis B virus.

Philippe Gripon1, Sylvie Rumin, Stephan Urban, Jacques Le Seyec, Denise Glaise, Isabelle Cannie, Claire Guyomard, Josette Lucas, Christian Trepo, Christiane Guguen-Guillouzo.   

Abstract

Among numerous established human hepatoma cell lines, none has been shown susceptible to hepatitis B virus (HBV) infection. We describe here a cell line, called HepaRG, which exhibits hepatocyte-like morphology, expresses specific hepatocyte functions, and supports HBV infection as well as primary cultures of normal human hepatocytes. Differentiation and infectability are maintained only when these cells are cultured in the presence of corticoids and dimethyl sulfoxide. The specificity of this HBV infection model was ascertained by both the neutralization capacity of HBV-envelope protein-specific antibodies and the competition with an envelope-derived peptide. HepaRG cells therefore represent a tool for deciphering the mechanism of HBV entry. Moreover, their close resemblance to normal human hepatocytes makes them suitable for many applications including drug metabolism studies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12432097      PMCID: PMC137772          DOI: 10.1073/pnas.232137699

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1.

Authors:  C Y Maeng; C J Ryu; P Gripon; C Guguen-Guillouzo; H J Hong
Journal:  Virology       Date:  2000-04-25       Impact factor: 3.616

2.  A short N-proximal region in the large envelope protein harbors a determinant that contributes to the species specificity of human hepatitis B virus.

Authors:  P Chouteau; J Le Seyec; I Cannie; M Nassal; C Guguen-Guillouzo; P Gripon
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Molecular cloning and sequence analysis of cDNA for human transferrin.

Authors:  G Uzan; M Frain; I Park; C Besmond; G Maessen; J S Trépat; M M Zakin; A Kahn
Journal:  Biochem Biophys Res Commun       Date:  1984-02-29       Impact factor: 3.575

4.  Nucleotide sequence of a cDNA clone for human aldolase B.

Authors:  C Besmond; J C Dreyfus; C Gregori; M Frain; M M Zakin; J Sala Trepat; A Kahn
Journal:  Biochem Biophys Res Commun       Date:  1983-12-16       Impact factor: 3.575

5.  Assays for differentiation of glutathione S-transferases.

Authors:  W H Habig; W B Jakoby
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

6.  Inhibition of duck hepatitis B virus infection by a myristoylated pre-S peptide of the large viral surface protein.

Authors:  Stephan Urban; Philippe Gripon
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

7.  Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain.

Authors:  J Le Seyec; P Chouteau; I Cannie; C Guguen-Guillouzo; P Gripon
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism.

Authors:  F P Guengerich; M V Martin; P H Beaune; P Kremers; T Wolff; D J Waxman
Journal:  J Biol Chem       Date:  1986-04-15       Impact factor: 5.157

9.  Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen.

Authors:  B B Knowles; C C Howe; D P Aden
Journal:  Science       Date:  1980-07-25       Impact factor: 47.728

10.  Nucleotide sequence and the encoded amino acids of human serum albumin mRNA.

Authors:  A Dugaiczyk; S W Law; O E Dennison
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

View more
  395 in total

1.  Therapeutic polypeptides based on HBcAg(18-27) CTL epitope can induce antigen-specific CD(8)(+) CTL-mediated cytotoxicity in HLA-A2 transgenic mice.

Authors:  Tong-Dong Shi; Yu-Zhang Wu; Zheng-Cai Jia; Wei Zhou; Li-Yun Zou
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

2.  CRM1-dependent transport supports cytoplasmic accumulation of adenoviral early transcripts.

Authors:  Melanie Schmid; Ramon A Gonzalez; Thomas Dobner
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

3.  Proteasome-dependent degradation of Daxx by the viral E1B-55K protein in human adenovirus-infected cells.

Authors:  Sabrina Schreiner; Peter Wimmer; Hüseyin Sirma; Roger D Everett; Paola Blanchette; Peter Groitl; Thomas Dobner
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

4.  Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation.

Authors:  Dawei Cai; Courtney Mills; Wenquan Yu; Ran Yan; Carol E Aldrich; Jeffry R Saputelli; William S Mason; Xiaodong Xu; Ju-Tao Guo; Timothy M Block; Andrea Cuconati; Haitao Guo
Journal:  Antimicrob Agents Chemother       Date:  2012-05-29       Impact factor: 5.191

Review 5.  Present and future therapies of hepatitis B: From discovery to cure.

Authors:  T Jake Liang; Timothy M Block; Brian J McMahon; Marc G Ghany; Stephan Urban; Ju-Tao Guo; Stephen Locarnini; Fabien Zoulim; Kyong-Mi Chang; Anna S Lok
Journal:  Hepatology       Date:  2015-10-27       Impact factor: 17.425

6.  NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism.

Authors:  Chia-Lin Chen; Dinesh Babu Uthaya Kumar; Vasu Punj; Jun Xu; Linda Sher; Stanley M Tahara; Sonja Hess; Keigo Machida
Journal:  Cell Metab       Date:  2015-12-24       Impact factor: 27.287

7.  From the Cover: Three-Dimensional (3D) HepaRG Spheroid Model With Physiologically Relevant Xenobiotic Metabolism Competence and Hepatocyte Functionality for Liver Toxicity Screening.

Authors:  Sreenivasa C Ramaiahgari; Suramya Waidyanatha; Darlene Dixon; Michael J DeVito; Richard S Paules; Stephen S Ferguson
Journal:  Toxicol Sci       Date:  2017-09-01       Impact factor: 4.849

8.  Nucleic Acid Polymers Are Active against Hepatitis Delta Virus Infection In Vitro.

Authors:  Frauke Beilstein; Matthieu Blanchet; Andrew Vaillant; Camille Sureau
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

9.  Optimization of Canalicular ABC Transporter Function in HuH-7 Cells by Modification of Culture Conditions.

Authors:  Hee Eun Kang; Melina M Malinen; Chitra Saran; Paavo Honkakoski; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2019-08-01       Impact factor: 3.922

10.  Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction.

Authors:  Andreas Schulze; Alexa Schieck; Yi Ni; Walter Mier; Stephan Urban
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.